Nihon Kohden (OTCMKTS:NHNKY) Sees Large Volume Increase – Here’s Why

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) saw an uptick in trading volume on Thursday . Approximately 28,894 shares changed hands during trading, an increase of 15% from the previous session’s volume of 25,081 shares.The stock last traded at $9.5280 and had previously closed at $9.58.

Wall Street Analyst Weigh In

Separately, UBS Group lowered shares of Nihon Kohden from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 12th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.

Nihon Kohden Stock Performance

The company has a market cap of $1.60 billion, a PE ratio of 17.34 and a beta of 0.36. The company has a fifty day moving average of $9.48 and a two-hundred day moving average of $9.41.

Nihon Kohden (OTCMKTS:NHNKY) last issued its earnings results on Thursday, August 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.09). The company had revenue of $297.47 million for the quarter, compared to analysts’ expectations of $299.98 million. Nihon Kohden had a net margin of 5.90% and a return on equity of 9.08%. On average, equities analysts forecast that Nihon Kohden Corporation will post 0.6 EPS for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.